These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 18224415)
1. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Souri M; Koseki-Kuno S; Takeda N; Degen JL; Ichinose A Int J Hematol; 2008 Jan; 87(1):60-8. PubMed ID: 18224415 [TBL] [Abstract][Full Text] [Related]
3. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Lauer P; Metzner HJ; Zettlmeissl G; Li M; Smith AG; Lathe R; Dickneite G Thromb Haemost; 2002 Dec; 88(6):967-74. PubMed ID: 12529747 [TBL] [Abstract][Full Text] [Related]
4. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement. Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939 [TBL] [Abstract][Full Text] [Related]
5. Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration. Byrnes JR; Lee T; Sharaby S; Campbell RA; Dobson DA; Holle LA; Luo M; Kangro K; Homeister JW; Aleman MM; Luyendyk JP; Kerlin BA; Dumond JB; Wolberg AS Blood; 2024 Feb; 143(5):444-455. PubMed ID: 37883802 [TBL] [Abstract][Full Text] [Related]
6. Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII. Souri M; Koseki-Kuno S; Takeda N; Yamakawa M; Takeishi Y; Degen JL; Ichinose A Thromb Haemost; 2008 Feb; 99(2):401-8. PubMed ID: 18278192 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency. Brand-Staufer B; Carcao M; Kerlin BA; Will A; Williams M; Tornøe CW; Sandberg Lundblad M; Nugent D Haemophilia; 2015 May; 21(3):380-385. PubMed ID: 25643920 [TBL] [Abstract][Full Text] [Related]
8. Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes. Carcao M; Fukutake K; Inbal A; Kerlin B; Lassila R; Oldenburg J; Garly ML; Nugent D Semin Thromb Hemost; 2017 Feb; 43(1):59-68. PubMed ID: 27556350 [TBL] [Abstract][Full Text] [Related]
9. Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking. Souri M; Yokoyama C; Osaki T; Ichinose A Thromb Haemost; 2023 Sep; 123(9):841-854. PubMed ID: 36934722 [TBL] [Abstract][Full Text] [Related]
10. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results. Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691 [TBL] [Abstract][Full Text] [Related]
12. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms. Biswas A; Ivaskevicius V; Thomas A; Oldenburg J Hamostaseologie; 2014; 34(2):160-6. PubMed ID: 24503678 [TBL] [Abstract][Full Text] [Related]
13. Factor XIII Deficiency. Karimi M; Bereczky Z; Cohan N; Muszbek L Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071 [TBL] [Abstract][Full Text] [Related]
14. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines. Souri M; Biswas A; Misawa M; Omura H; Ichinose A Haemophilia; 2014 Mar; 20(2):255-62. PubMed ID: 24286209 [TBL] [Abstract][Full Text] [Related]
15. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Levy JH; Greenberg C Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875 [TBL] [Abstract][Full Text] [Related]
16. Congenital blood coagulation factor XIII deficiency and perinatal management. Ichinose A; Asahina T; Kobayashi T Curr Drug Targets; 2005 Aug; 6(5):541-9. PubMed ID: 16026274 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients. Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599 [TBL] [Abstract][Full Text] [Related]
18. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency. Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency. Kerlin B; Brand B; Inbal A; Halimeh S; Nugent D; Lundblad M; Tehranchi R J Thromb Haemost; 2014 Dec; 12(12):2038-43. PubMed ID: 25263390 [TBL] [Abstract][Full Text] [Related]
20. Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers. Reynolds TC; Butine MD; Visich JE; Gunewardena KA; MacMahon M; Pederson S; Bishop PD; Morton KM J Thromb Haemost; 2005 May; 3(5):922-8. PubMed ID: 15869585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]